Search results
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 7 days agoFree Report) has recently been on Zacks.com's list of the most searched stocks. During this period, the Zacks Large Cap Pharmaceuticals industry, which Pfizer falls in, has ...
Pfizer Inc. (NYSE:PFE) Shares Sold by Cresset Asset Management LLC
ETF DAILY NEWS· 5 days agoCresset Asset Management LLC reduced its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent disclosure ...
Pfizer faces setback with gene therapy acquired from North Carolina firm - Triangle Business Journal
The Business Journals· 3 days agoPfizer is facing a major clinical setback in a gene therapy program with ties to the Triangle. The...
Pfizer, Flagship name first target for multibillion-dollar collaboration: obesity
FierceBiotech· 5 days agoPfizer and Flagship Pioneering have settled on the first target for their billion-dollar,...
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 4 days agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 3 days agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...
UPDATE: Pfizer's phase 3 gene therapy trial fails to improve function for boys with Duchenne...
FierceBiotech· 4 days agoPfizer’s phase 3 gene therapy trial has failed to demonstrate significant improvement in motor...
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open
Barrons.com· 3 days agoThe drug company Pfizer said a gene therapy it is testing failed to improve motor function in boys...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters· 4 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...